Takeda Pharmaceuticals International GmbH
Industry / private company
Location:
Zürich,
Switzerland (CH)
ROR: https://ror.org/002ysmy84
Preferences, attitudes and views regarding genetic newborn screening (gNBS) for rare diseases: a systematic review of the literature and synthesis from 2009 to 2022 (2026)
Martin S, Kyosovska-Peshtenska G, Audi J, Zarakowska K, Grauman Å, Veldwijk J, Hauber B, et al.
Journal article, Review article
Patient preferences in genetic newborn screening for rare diseases: study protocol (2024)
Martin S, Angolini E, Audi J, Bertini E, Bruno LP, Coulter J, Ferlini A, et al.
Journal article
Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in Europe (2023)
Garnier N, Berghout J, Zygmunt A, Singh D, Huang KA, Kantz W, Blankart CR, et al.
Journal article